Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Common Equity: 2009-2024

Historic Common Equity for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to $17.1 billion.

  • Fresenius Medical Care AG's Common Equity rose 9.84% to $16.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 billion, marking a year-over-year increase of 9.84%. This contributed to the annual value of $17.1 billion for FY2024, which is 698.58% up from last year.
  • Fresenius Medical Care AG's Common Equity amounted to $17.1 billion in FY2024, which was up 698.58% from $16.0 billion recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Common Equity registered a high of $17.1 billion during FY2024, and its lowest value of $14.1 billion during FY2020.
  • Moreover, its 5-year median value for Common Equity was $16.0 billion (2021), whereas its average is $15.9 billion.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Common Equity plummeted by 495.48% in 2020, and later skyrocketed by 1358.03% in 2021.
  • Over the past 5 years, Fresenius Medical Care AG's Common Equity (Annual) stood at $14.1 billion in 2020, then grew by 13.58% to $16.0 billion in 2021, then increased by 1.82% to $16.3 billion in 2022, then dropped by 2.03% to $16.0 billion in 2023, then increased by 6.99% to $17.1 billion in 2024.
  • Its last three reported values are $17.1 billion in FY2024, $16.0 billion for FY2023, and $16.3 billion during FY2022.